Innoviva Yönetim
Yönetim kriter kontrolleri 4/4
Innoviva's CEO is Pavel Raifeld, appointed in May 2020, has a tenure of 4.5 years. total yearly compensation is $868.65K, comprised of 55.8% salary and 44.2% bonuses, including company stock and options. directly owns 0.019% of the company’s shares, worth $224.72K. The average tenure of the management team and the board of directors is 2.9 years and 6.8 years respectively.
Anahtar bilgiler
Pavel Raifeld
İcra Kurulu Başkanı
US$868.6k
Toplam tazminat
CEO maaş yüzdesi | 55.8% |
CEO görev süresi | 4.5yrs |
CEO sahipliği | 0.02% |
Yönetim ortalama görev süresi | 2.9yrs |
Yönetim Kurulu ortalama görev süresi | 6.8yrs |
Son yönetim güncellemeleri
Recent updates
Benign Growth For Innoviva, Inc. (NASDAQ:INVA) Underpins Its Share Price
Jul 26Innoviva: Potentially Overvalued
Jun 21Why Innoviva's (NASDAQ:INVA) Shaky Earnings Are Just The Beginning Of Its Problems
May 21Here's Why Innoviva (NASDAQ:INVA) Can Manage Its Debt Responsibly
Feb 05Is Innoviva (NASDAQ:INVA) A Risky Investment?
Nov 04Innoviva (NASDAQ:INVA) Seems To Use Debt Quite Sensibly
Mar 02Innoviva Stock? Not Yet. Short Puts? Definitely.
Sep 19Does Innoviva (NASDAQ:INVA) Have A Healthy Balance Sheet?
Sep 19Does Innoviva (NASDAQ:INVA) Have A Healthy Balance Sheet?
Jun 16Continuing To Avoid Innoviva Inc.
Jun 07We Think Innoviva (NASDAQ:INVA) Can Manage Its Debt With Ease
Mar 04Taking Innoviva Winnings Off The Table, Again
Feb 21Innoviva Inc.: Short Puts Are Compelling
Jan 15Is Innoviva (NASDAQ:INVA) A Risky Investment?
Oct 19Taking Profits In Innoviva Inc.
Oct 16Innoviva reports Q1 results
Apr 28These 4 Measures Indicate That Innoviva (NASDAQ:INVA) Is Using Debt Safely
Mar 30Is Weakness In Innoviva, Inc. (NASDAQ:INVA) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Mar 04Did Innoviva's (NASDAQ:INVA) Share Price Deserve to Gain 36%?
Jan 15These 4 Measures Indicate That Innoviva (NASDAQ:INVA) Is Using Debt Safely
Dec 25Will Weakness in Innoviva, Inc.'s (NASDAQ:INVA) Stock Prove Temporary Given Strong Fundamentals?
Dec 04Innoviva: Only For Short-Term Traders
Nov 04Innoviva reports Q3 results
Oct 28CEO Tazminat Analizi
Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
---|---|---|---|
Jun 30 2024 | n/a | n/a | US$145m |
Mar 31 2024 | n/a | n/a | US$181m |
Dec 31 2023 | US$869k | US$485k | US$180m |
Sep 30 2023 | n/a | n/a | US$50m |
Jun 30 2023 | n/a | n/a | US$233m |
Mar 31 2023 | n/a | n/a | US$233m |
Dec 31 2022 | US$2m | US$440k | US$214m |
Sep 30 2022 | n/a | n/a | US$293m |
Jun 30 2022 | n/a | n/a | US$99m |
Mar 31 2022 | n/a | n/a | US$188m |
Dec 31 2021 | US$1m | US$391k | US$266m |
Sep 30 2021 | n/a | n/a | US$309m |
Jun 30 2021 | n/a | n/a | US$265m |
Mar 31 2021 | n/a | n/a | US$253m |
Dec 31 2020 | US$2m | US$222k | US$224m |
Tazminat ve Piyasa: Pavel's total compensation ($USD868.65K) is below average for companies of similar size in the US market ($USD5.64M).
Tazminat ve Kazançlar: Pavel's compensation has been consistent with company performance over the past year.
CEO
Pavel Raifeld (40 yo)
4.5yrs
Görev süresi
US$868,648
Tazminat
Mr. Pavel Raifeld, CFA, is Director of La Jolla Pharmaceutical Company since August 22, 2022. He serves as Chief Executive Officer of Innoviva, Inc. since May 2020. He is a seasoned healthcare executive wi...
Liderlik Ekibi
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
Chief Executive Officer | 4.5yrs | US$868.65k | 0.019% $ 224.7k | |
Chief Financial Officer | 1.3yrs | US$1.18m | Veri yok | |
Chief Accounting Officer & Secretary | 6.3yrs | US$924.21k | 0.073% $ 878.5k | |
Chief Commercial Officer-Innoviva Specialty Therapeutics | less than a year | Veri yok | Veri yok |
2.9yrs
Ortalama Görev Süresi
56.5yo
Ortalama Yaş
Deneyimli Yönetim: INVA's management team is considered experienced (2.9 years average tenure).
Yönetim Kurulu Üyeleri
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
Independent Director | 6.8yrs | US$446.02k | 0.19% $ 2.3m | |
Independent Director | 1.8yrs | US$547.11k | 0.041% $ 490.3k | |
Independent Director | less than a year | Veri yok | Veri yok | |
Independent Director | 6.9yrs | US$331.18k | 0.17% $ 2.1m | |
Independent Director | 6.8yrs | US$367.25k | 0.17% $ 2.0m | |
Independent Director | 6.8yrs | US$396.59k | 0.17% $ 2.0m |
6.8yrs
Ortalama Görev Süresi
52.5yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: INVA's board of directors are considered experienced (6.8 years average tenure).